In studies of female patients with suspected deficiency of the Elm subunit of the pyruvate dehydrogenase complex, we have found that X inactivation ratios of 80:20 or greater occur at sufficient frequency in cultured fibroblasts to make exclusion of the diagnosis impossible in about 25% of cases. Pyruvate dehydrogenase Elm subunit deficiency is an X linked inborn error of metabolism which is well defined biochemically and is unusual in that most heterozygous females manifest the condition. The diagnosis is usually established by measurement of enzyme activity and the level of immunoreactive protein and these analyses are most commonly performed on cultured fibroblasts from the patients. Skewed patterns of X chromosome inactivation make it impossible to exclude the diagnosis if the normal X chromosome is expressed in the majority of cells. While most of the observed variation appears to be the expected consequence of random X inactivation, it may be further exaggerated by sampling and subsequent expansion of the cells for analysis.
There are relatively few X linked diseases which are expressed in most heterozygous females and for which the responsible gene and its product have been defined. As a consequence, relatively little attention has been given to problems which might arise in this situation when diagnosis is based on measurement of the function or structure of the gene product. One example of an X linked disease which does behave in this way is pyruvate dehydrogenase (PDH) Elca subunit deficiency. This is a relatively common inborn error of metabolism with a broad spectrum of clinical presentation ranging from severe lactic acidosis in the newborn to a progressive neurodegenerative disease with prolonged survival.l1
The PDH complex is an important and widely distributed housekeeping enzyme which catalyses the conversion of pyruvate to acetyl coenzyme A within the mitochondrion. This is a key regulatory step in the central pathways of energy production in the cell and the enzyme operates at close to its maximal activity in a number of tissues. This is particularly important in the brain which has an obligatory requirement for aerobic glucose oxidation under normal circumstances. Relatively modest reduction in PDH activity therefore has significant consequences, especially for central nervous system function.
Within the PDH complex, the Ela subunit contains the pyruvate binding site and the phosphorylation sites by which the activity of the whole complex is controlled. 5 The gene for the Elca subunit is located on the short arm of the X chromosome in the region Xp22. 1. 6 However, in all reported series of patients with PDH Ela deficiency, there are approximately equal numbers of males and females.2-The clinical presentation does differ between the sexes with the acute metabolic form more common in males and neurological presentations predominating in females. The disorder in females, although generally less severe, still usually results in death before adulthood and only a few subjects with mutations in the Ela gene are known to have had children. PDH Ela deficiency therefore represents an unusual case of an X linked disease involving a housekeeping gene product, in which almost all cases are sporadic and where the threshold for developing symptoms is so low that it is usually exceeded in heterozygous females.
The diagnosis of PDH Ela deficiency is usually established in the first instance by measurement of enzyme activity in samples from the patients. Most commonly, cultured fibroblasts from a skin biopsy are used, although results obtained with lymphoid cells or tissue biopsy samples are occasionally reported. In conjunction with these enzyme assays, most laboratories also determine the levels of immunoreactive protein corresponding to the different subunits of the complex. Subsequently, the underlying mutation may be defined but, at present, direct analysis of the basic gene defect is not feasible as a primary screening procedure.
For reliable diagnosis of PDH Ela deficiency in females, it is essential that each X chromosome is represented in the active form in a significant proportion of the cells in the sample. Increasing deviation away from approximately equal representation towards a situation in which the normal X chromosome is expressed in the majority of cells will make it progressively more difficult to identify the presence of an El x mutation against the background of considerable normal variation in enzyme activity. In practice, less than 20% representation of an X chromosome with a null EhIo mutation would not be detectable.
In this paper, we compare methods for X inactivation analysis in cultured human fibroblasts and assess the significance of the observed variation in the pattern of X inactivation for the diagnosis of PDH Elax deficiency in females based on experience with 48 patients. We also present data on X chromosome inactivation patterns in chorionic villus cell cultures which indicate that these are often unsuitable for the diagnosis of X linked disease based on measurements of gene expression.
Materials and methods

CELL CULTURE
Fibroblasts from forearm skin biopsies were cultured in Basal Medium (Eagle) with 10% fetal calf serum, 100 units/ml penicillin, and 100 pg/ml streptomycin. Cultures were always split at high density to minimise the possibility of expanding small cell populations and introducing a sampling bias. The cultures were regularly screened for mycoplasma contamination using the method of Chen.7 Chorionic villus cell cultures were established in Chang medium from cleanly dissected villi. They were subsequently cultured in Ham's F10 medium containing 20% fetal calf serum, 2% Ultraser G (Gibco), 100 units/ml penicillin, and 100 ptg/ml streptomycin. The possibility of clonal expansion during subsequent subculture was again reduced by ensuring that the cultures were never allowed to grow up from low density. ENZYME ASSAY Overall PDH activity was measured after max Analysis of methylation at the PGKI locus was performed using a double digest with PstI and BstXI to show the polymorphism, followed by digestion with HpaII.O0 The fragment sizes generated are 1-05 and 0 90 kb (figs 1 to 3C). The active X chromosome is unmethylated in the region detected by the probe and the inactive X is methylated. The bands remaining after digestion are therefore a measure of the inactive X chromosome unlike the M271B system in which bands generated after HpaII digestion, rather than residual band intensity, are a measure of the inactive X chromosome. Four of the chorionic villus samples studied were received for prenatal diagnosis of PDH Eloa deficiency and the remaining 19 samples were studied as controls. Two of the samples for diagnosis had normal levels of enzyme activity and had X inactivation patterns in the range 30:70 and 60:40 respectively and they were considered to be normal. The other two also had normal enzyme activity but had almost unilateral patterns of X inactivation (90:10) and so the diagnosis could not be excluded.
Discussion
The high frequency of manifestation of X linked PDH Ela deficiency in heterozygous females, combined with the fact that the majority of cases are sporadic, can lead to considerable diagnostic problems. Diagnosis based on gene expression demands that both X chromosomes are active in the sample at a sufficient level to ensure that their products, or lack thereof, are readily detectable. In this study, we show that this cannot be assumed in fibroblast cultures from human females and that the diagnosis cannot be excluded in a significant number of patients in whom there is a high index of clinical suspicion.
There are a number of different methods currently in use for the analysis of X inactivation patterns, none of which is entirely satisfactory for all situations. All are based on different patterns of methylation on active and inactive X chromosomes. Most commonly, use is made of methylation of cytosine residues within the 5' promoter regions of housekeeping genes such as PGK on the inactive X chromosome.'0 Although the methylation patterns at these loci are closely correlated with X inactivation, the loci themselves tend to be conserved and relatively few females are heterozygous for different alleles. The analysis is therefore informative in only a minority of cases (28% with PGK in the present study).
Another approach is based on the hypervariable locus, DXS255, which although not expressed, is differentially methylated on active and inactive X chromosomes.'2 Because this locus contains a VNTR sequence, it is highly polymorphic and virtually all females are informative (90% in this study). However, questions have been raised concerning the general use of DXS255 for X inactivation analysis. Firstly, methylation at this locus is associated with the active X chromosome,'2 the opposite to the situation with expressed genes. Secondly, hypermethylation of this locus has been observed in some cell types, in particular peripheral blood leucocytes and some malignant cells. '5 1718 In this case, more than half of the DNA in the sample remains undigested with HpaII and interpretation of the results relies on the assumption that there is no allele specific difference in the hypermethylation to distort the intensity of the bands representing digested DNA. Hypermethylation may also result in very faint fragment patterns in some samples which are difficult to analyse. '8 An additional problem may arise with the use of the DXS255 locus owing to differences in methylation at sites on either side of the VNTR sequence. This has been shown in white blood cells where it appears that only methylation at the 5' sites correlates well with the active X chromosome. '7 Digestion with PstI/HpaII removes the 3' methylation site from the analysis and could potentially provide clearer results. As differences in methylation on either side of the VNTR had not been studied previously in cultured fibroblasts, additional analysis was performed in a number of cases. However, no significant difference was observed in patterns generated by either BamHI/HpaII or PstI/HpaII (table) , and the complexity of the PstI/HpaII fragment patterns often made interpretation difficult (three of 25 patient samples could not be analysed because of overlapping bands).
The general complexity of methylation analysis at the DXS255 locus has been considered a major factor restricting the widespread use of this locus for X inactivation studies. Recently, however, much of the complexity has been removed by detailed restriction mapping and sequencing."' These studies have provided an explanation for different fragment patterns and led to more rational experimental design, based on specific methylated sites. The MspI sites used for methylation analysis are located within the CpG island of a LINE-1 repetitive element which is extensively methylated on the inactive X chromosome.
In the present study, a close correlation was found between X inactivation patterns determined with either PGK or M273 in nine patient samples and three normal control samples where both were informative. This is in agreement with the study of Gale et all5 in which a similar correlation was shown between the two methods in blood and bone marrow samples from 37 females. We have also previously shown a good correlation between the X inactivation pattern determined with M27f and expression of the PDH ElIa gene9 and these observations have been further confirmed and extended in the present study. The conclusion is that this system provides a reliable guide to X inactivation status in cultured fibroblasts.
The results show wide variation in the pattern of X inactivation in fibroblast cultures from different females (fig 4) . 15 (23%) had an X inactivation ratio > 3/1 and, of 23 post-chemotherapy patients, 26% had ratios > 3/1. In a second study using DXS255, results were obtained from 41 females, including both normal controls and haematologically normal patients post-chemotherapy."' Nine of these (22%) had X inactivation ratios which were highly skewed. In these studies, the frequency of extreme X inactivation ratios is very similar to the present findings in cultured fibroblasts, where 24% had ratios of 80:20 or greater. In addition to the variation between different females defined in these studies, there appear to be considerable differences in X inactivation patterns in different tissues of the same subject.9
In the absence of biological or in vitro selection for particular cell populations, random X inactivation should result in proportions which follow a binomial distribution; however, the results in fig 4 show a bias and identification of carriers of X linked immunodeficiencies. 20 While exclusion of the diagnosis of PDH Ela deficiency in cultured fibroblasts may be impossible in up to 25% of cases, greater problems can arise with prenatal diagnosis based on measurements of PDH activity in chorionic villus cell cultures as these are likely to be clonal. Although chorionic villi contain a mixed population of cells, the established cultures are composed of fibroblast cells derived from the mesodermal core23 and may represent expansion of only a few clones. Coupled with this is the observed hypomethylation in some of these cultures which may make direct analysis of the X inactivation pattern difficult. Although hypomethylation was observed at both the DXS255 and PGKI loci, it appears to be more extreme at the PGK locus as, in seven out of eight samples, the inactive X chromosome was unmethylated in the 5' region of this gene. Hypomethylation of the inactive X chromosome in chorionic villus cells has been reported previously24 and methylation status in the fetus may also vary during development. 25 For these reasons, methylation may differ with the timing of the chorionic villus biopsy and may alter further during successive passages in culture. It is at present uncertain if methylation status in chorionic villus cells can be reliably correlated with X inactivation.
The spectrum of PDH Ela deficiency in females has not been fully defined as there is a bias towards ascertainment of more severely affected patients. Recognition of milder cases or asymptomatic carriers of this and other X linked diseases may be even more problematical as an X inactivation pattern skewed towards expression of the normal X chromosome may be the major determinant of their phenotype. In the case of PDH Ela deficiency, we believe that patients with a convincing clinical presentation (including typical cerebral pathology and raised blood or cerebrospinal fluid lactate concentration), normal enzyme activity, and a skewed X inactivation pattern should be screened directly for a mutation in the PDH Elao gene. Similarly, demonstration of the mutation in an affected subject is a desirable precondition for prenatal diagnosis so that the presence or absence of the same mutation in the fetus can be determined directly. This avoids the problem of non-representation of the mutant gene product which would give a false negative result.
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